Australian-founded medical technology company SYMBYX today announced compelling results from a 72-week randomized controlled ...

The cell therapy field has long held a transformative ambition: to create "off-the-shelf" treatments that can reach not just ...

Ahead of Little Big Town's Nashville Christmas residency, the chart-topping country artist opens up about her mother's ...

Research on Parkinson’s is revealing several risk factors related to our lifestyles and environment, and you can act on some ...

Gibson's most famous moment came 37 years ago this month. Now he's leading another team towards a very different goal.

A woman living with Parkinson’s disease played her clarinet while undergoing brain stimulation, offering surgeons immediate, ...

Parkinson’s is the fastest-growing neurodegenerative condition in the world, and the Coachella Valley is uniquely affected ...

Transcutaneous afferent patterned stimulation is linked to metabolic activity changes in the cerebellum and other brain areas ...

On a grey October morning in Exeter, 35-year-old personal trainer Tom Burridge laced up his trainers, pulled on a comically ...

Glovadalen, a novel D1 receptor positive allosteric modulator, is linked to improve OFF time in patients with Parkinson’s ...

In today's Daily Briefing, we tell you about local programs using innovative therapies for Parkinson's patients, why the city ...

Subthalamic deep brain stimulation is an effective long-term therapy for Parkinson disease, according to a recent study.